1mg company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Founded Year



Corporate Majority | Alive

Total Raised






Mosaic Score

+70 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About 1mg

1mg operates an online consumer wellness store. The company's platform provides products for diabetes, bodybuilding supplements, home medical and baby products, elderly care, nutrition, personal care, chronic care, vision care, and skincare.On June 10, 2021, Tata Group acquired a majority stake in 1mg. The terms of the transaction were not disclosed.

1mg Headquarter Location

5th Floor Tower – B of The Presidency Building 46/4 Mehrauli Gurgaon Road, Sector 14

Gurgaon, Haryana, 122001,


+91 124 416 6666

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing 1mg

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned 1mg in 3 CB Insights research briefs, most recently on Nov 30, 2021.

Expert Collections containing 1mg

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

1mg is included in 4 Expert Collections, including E-Commerce.



9,318 items


Wellness Tech

1,287 items

We define wellness tech as companies developing technology to help consumers improve their physical, mental, and social well-being. Companies in this collection play across a wide range of categories, including food and beverage, fitness, personal care, and corporate wellness.



1,750 items


Digital Health

12,800 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Latest 1mg News

Apex Chemists’ Body Calls Out 1MG Yet Again, Writes To Ratan Tata Over Its Alleged Malpractices

Sep 30, 2021

Tata Digital announced a majority stake acquisition in 1MG in June 2021 The chemists’ body has alleged that 1MG sells prescription medicine to individuals in bulk “from so-called doctors on its panel”, citing it illegal The All India Organisation of Chemists & Druggists (AIOCD) representing 9.4 Lakh chemists and pharmaceutical distributors in India, has yet again called out the Delhi NCR-based online pharmaceutical service provider 1MG. In a letter, seen by Inc42, the apex chemist’ body has reached out to Tata Group’s Chairman Emeritus Ratan Tata complaining that theTata-owned company is allegedly taking illegal ways to sell medicines. Citing a communication between a 1MG representative and AIOCD, and citing Section 65(9) of the Drugs and Cosmetics Act, the chemists’ body has alleged that the e-pharmacy sells bulk medicines to individuals, from so-called doctors, on its panel, going against the law, even selling Schedule H and H1 medicines Schedule H and H1 are the categories which as per the law should be sold under prescription of a registered medical practitioner only, but the norm regarding drugs under Schedule H1 are stricter. “We want to bring to your notice the way 1MG wants to increase its sales – by selling prescription medicines in B2B sales to chemists, against the laws,” said the letter signed from AIOCD president JS Shinde, and general secretary Rajiv Singh. AIOCD also claims to have written to Tata in November 2020 suggesting against any possible investment in the startup. It claims that in the conversation with the unnamed 1MG representative, 1MG sells prescription medicines to chemists in B2B sales at 30%, does now take any returns in case of breakage and expiry and bills in individual name and 1MG’s name. Tata-1MG: A Match Made For Super App – TataNeu In June 2021, Tata Digital, a 100% subsidiary of Tata Sons announced a majority stake in the Delhi NCR-based epharmacy and telemedicine startup as part of its super app play. The one-stop platform — named TataNeu — will offer hotel bookings, electronics and grocery shopping and e-pharmacy, among others, which is set to launch in early 2022 . Founded in 2015 by Prashant Tandon, Gaurav Agarwal, and Vikas Chauhan, 1MG offers medicine delivery, health & wellness products, B2B distribution of medicines & other healthcare products, diagnostics services as well as telemedicine services. It operates three diagnostics labs, and claims to have a supply chain covering over 20,000 postal codes. The epharmacy and telemedicine segment has witnessed a robust growth in the past few years with several startups coming up, which have also drawn interest from large corporates. Last year, Reliance Retail, the subsidiary of Reliance Industries Ltd (RIL) bought a majority stake in Netmeds for INR 620 Cr. Another major player PharmEasy is expected to take the IPO route and may file a draft red herring prospectus soon. According to a BofA Securities consumer survey in May 2021, pharmacies Medlif and Pharmeasy lead in market share with 22% and 18% market share respectively followed by 1MG with 13% market share.

1mg Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

1mg Rank

  • When was 1mg founded?

    1mg was founded in 2015.

  • Where is 1mg's headquarters?

    1mg's headquarters is located at 5th Floor Tower – B of The Presidency Building, Gurgaon, Haryana.

  • What is 1mg's latest funding round?

    1mg's latest funding round is Corporate Majority.

  • How much did 1mg raise?

    1mg raised a total of $148.13M.

  • Who are the investors of 1mg?

    Investors of 1mg include Paycheck Protection Program.

  • Who are 1mg's competitors?

    Competitors of 1mg include SastaSundar and 8 more.

You May Also Like

PharmEasy Logo

PharmEasy is a medicine and healthcare provider that operates an India-based online pharmacy & medical store offering pharmaceutical and healthcare products. As a healthcare aggregator, PharmEasy helps patients connect with local pharmacy stores and diagnostic centers in order to fulfill their medical needs.

Apollo 247

Apollo 247 is the digital business unit of Apollo Hospitals. Apollo 247 helps individuals get treated from Apollo certified doctors. The mobile app has features like E- consultation, online pharmacy, home diagnostic test and digital vault where users can upload all their medical history.

Practo Technologies

Practo Technologies is a healthcare services platform that provides a practice management and appointment scheduling software for doctors and clinics, as well as a hospital information management solution - all on a software as a service model. In addition, Practo offers a sponsored listing service for hospitals and clinics.

eVital Logo

eVital develops cloud-based applications for independent healthcare practitioners like pharmacists, labs, and doctors. The idea is to have all the applications (Mobile and Web) based on the same cloud-platform, such that patients can access all the records from a single interface.

LifCare Logo

LifCare is a subscription pharmacy targeting patients with chronic illnesses like diabetes, cardiac conditions, hypertension, renal disorders, thyroid, etc.

Mfine Logo

Mfine is an artificial intelligence-driven healthcare network. Mfine aims to offer on-demand healthcare platform that gives users access to virtual consultations with doctors via chat or video. Per the company, the app also allows users to book routine lab tests, medicine delivery and access comprehensive health packages.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.